A Quantum Shift in the Diagnosis and Treatment of Neurological Disorders
About Neurolign
Neurolign is driven by an overarching ethos of accessibility – making sophisticated eye-tracking equipment and brain health detection technology a viable option for a greater number of organizations and institutions, while also bringing the most widely applicable aspects of this pioneering technology into everyday homes. Neurolign’s FDA-cleared devices have had more than 150 installations and are backed by over 30 years of research, experience, and development.
88
Unique Test Variables Measured
16
Clinical Tests with Normative Data
200
Customer Sites and Installs
30
Combined Years of Experience
60
Peer-Reviewed Publications
30
Patents and Patents Pending